CSIMarket
 


Emmaus Life Sciences Inc   (EMMAW)
Other Ticker:  
 
 

EMMAW's Net Income Growth by Quarter and Year

Emmaus Life Sciences Inc 's Net Income results by quarter and year




EMMAW Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.20 -6.86 32.87
III Quarter September 0.07 -0.39 -3.15 5.59
II Quarter June -1.48 -8.89 2.49 -9.47
I Quarter March -3.53 -1.54 -8.42 5.51
FY   -4.94 -10.62 -15.94 34.50



EMMAW Net Income third quarter 2023 Y/Y Growth Comment
Emmaus Life Sciences Inc in the third quarter 2023 achieved Net Income of $ 0.07 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the third quarter 2023, Emmaus Life Sciences Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Emmaus Life Sciences Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.




EMMAW Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Emmaus Life Sciences Inc 's third quarter 2023 Net Income $ 0.07 millions EMMAW's Income Statement
Emmaus Life Sciences Inc 's third quarter 2022 Net Income $ -0.39 millions Quarterly EMMAW's Income Statement
New: More EMMAW's historic Net Income Growth >>


EMMAW Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - 488.01 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Emmaus Life Sciences Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EMMAW's III. Quarter Q/Q Net Income Comment
Improvement III. Quarter 2023where Emmaus Life Sciences Inc delivered Net Income of $ 0.07 millions could be considered as a inception of positive business climet.Emmaus Life Sciences Inc announced in the III. Quarter 2023 Net Income of $ 0.07 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Emmaus Life Sciences Inc achieved highest sequential Net Income growth. While Emmaus Life Sciences Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EMMAW's III. Quarter Q/Q Net Income Comment
This turnaround III. Quarter 2023where Emmaus Life Sciences Inc delivered Net Income of $ 0.07 millions should is beginning of positive results.Emmaus Life Sciences Inc announced in the III. Quarter 2023 Net Income of $ 0.07 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Emmaus Life Sciences Inc achieved highest sequential Net Income growth. While Emmaus Life Sciences Inc 's Net Income growth quarter on quarter, overall rank is .


Emmaus Life Sciences Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -4.74 $ -5.20 $ -12.61 $ -10.63 $ -17.69
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Emmaus Life Sciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Emmaus Life Sciences Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
EMMAW's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for EMMAW's Competitors
Net Income Growth for Emmaus Life Sciences Inc 's Suppliers
Net Income Growth for EMMAW's Customers

You may also want to know
EMMAW's Annual Growth Rates EMMAW's Profitability Ratios EMMAW's Asset Turnover Ratio EMMAW's Dividend Growth
EMMAW's Roe EMMAW's Valuation Ratios EMMAW's Financial Strength Ratios EMMAW's Dividend Payout Ratio
EMMAW's Roa EMMAW's Inventory Turnover Ratio EMMAW's Growth Rates EMMAW's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2023
Shockwave Medical Inc -0.05%$ -0.049 millions
Xeris Biopharma Holdings Inc -0.29%$ -0.295 millions
Tenet Healthcare Corp-0.75%$ -0.746 millions
U S Physical Therapy Inc-4.67%$ -4.672 millions
Universal Health Services Inc -4.98%$ -4.979 millions
National Research Corporation-5.09%$ -5.086 millions
Hca Healthcare Inc -5.13%$ -5.134 millions
Viatris Inc -6.41%$ -6.407 millions
Pacific Health Care Organization Inc -6.71%$ -6.710 millions
Mettler toledo International Inc -8.60%$ -8.598 millions
Corcept Therapeutics Inc-9.78%$ -9.777 millions
Charles River Laboratories International inc -9.83%$ -9.826 millions
Third Harmonic Bio Inc -10.51%$ -10.506 millions
The Pennant Group Inc -10.65%$ -10.653 millions
Henry Schein Inc-11.73%$ -11.728 millions
Quest Diagnostics Inc-14.13%$ -14.130 millions
Stryker Corp-15.20%$ -15.196 millions
Zimmer Biomet Holdings Inc -16.12%$ -16.117 millions
Amgen Inc -19.27%$ -19.272 millions
Entera Bio Ltd -22.43%$ -22.432 millions
Regeneron Pharmaceuticals Inc -23.40%$ -23.402 millions
Zynex inc -26.25%$ -26.247 millions
Evofem Biosciences Inc -26.26%$ -26.256 millions
Pediatrix Medical Group Inc -30.39%$ -30.386 millions
Tenax Therapeutics Inc -32.39%$ -32.386 millions
Avantor Inc -35.09%$ -35.090 millions
Ufp Technologies Inc -40.15%$ -40.154 millions
Bio techne Corp-43.17%$ -43.173 millions
Royalty Pharma Plc-44.61%$ -44.615 millions
American Shared Hospital Services-46.43%$ -46.429 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com